<DOC>
	<DOCNO>NCT00521040</DOCNO>
	<brief_summary>Efficacy Safety Levocetirizine 8 Weeks Prior After Onset Grass Pollen Season Subjects With SAR</brief_summary>
	<brief_title>Efficacy Safety Levocetirizine 8 Weeks Prior After Onset Grass Pollen Season Subjects With SAR</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>male female subject ≥ 12 year 2 year history seasonal allergic rhinitis document hypersensitivity local seasonal allergen ( grass pollen ) document polleninduced asthma without acute ongoing exacerbation asthma allergic rhinitis continuous ongoing treatment rhinitis asthma nonallergic rhinitis anatomic abnormality disturb analysis nasal capacity symptomatic rhinitis asthma due tree pollen currently treat specific grass pollen immunotherapy suffer nonallergic asthma chronic use inhale steroid and/or long act β2 agonist ; and/or corticosteroid dependent asthma atopic dermatitis urticaria require antihistamine treatment administration oral topical corticosteroid contraindication salbutamol use</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Levocetirizine dihydrochloride</keyword>
	<keyword>Xyzal tablet</keyword>
</DOC>